ClinicalTrials.Veeva

Menu

Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI (OPTIMUM)

S

Sunnybrook Health Sciences Centre

Status

Completed

Conditions

Prostate Cancer

Treatments

Diagnostic Test: MRI Targeted Biopsy
Diagnostic Test: Microultrasonography Targeted Biopsy

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05220501
EVU-2021-001

Details and patient eligibility

About

OPTIMUM is a study designed to compare the ability of ultra-high resolution transrectal micro-ultrasound (microUS) and multiparametric MRI (mpMRI)/US fusion to guide prostate biopsy.

Full description

The purpose of the Clinical Investigation Plan and Study Protocol is to present information for the OPTIMUM clinical investigation, including the scientific basis for the study, the procedural details, the ExactVu High Resolution Micro-Ultrasound System, its safety details, and administrative details. It has been designed in such a way as to optimize the scientific validity and reproducibility of the results of the study in accordance with current clinical knowledge and practice so as to fulfill the objectives of the investigation.

Enrollment

804 patients

Sex

Male

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Men indicated for prostate biopsy due to elevated Prostate Specific Antigen and/or abnormal Digital Rectal Examination
  • No history of prior prostate biopsy
  • No history of genitourinary cancer, including prostate cancer
  • 18 years or older
  • No contraindications to biopsy
  • No contraindications to mpMRI
  • No history of mpMRI for clinical investigation of prostate cancer within 12 months prior to screening and enrollment in the study

Exclusion criteria

  • History of prior prostate biopsy
  • History of genitourinary cancer, including prostate cancer
  • Contraindications to biopsy
  • Contraindications to mpMRI

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

804 participants in 3 patient groups

Microultrasonography only
Active Comparator group
Description:
Subjects will undergo biopsy using micro-ultrasound only.
Treatment:
Diagnostic Test: Microultrasonography Targeted Biopsy
Microultrasonography + MRI
Active Comparator group
Description:
Subjects will undergo fusion biopsy using mpMRI and micro-ultrasound
Treatment:
Diagnostic Test: Microultrasonography Targeted Biopsy
Diagnostic Test: MRI Targeted Biopsy
MRI + Conventional Ultrasonography
Active Comparator group
Description:
Subjects will undergo biopsy using mpMRI fused with regular ultrasound
Treatment:
Diagnostic Test: MRI Targeted Biopsy

Trial documents
1

Trial contacts and locations

22

Loading...

Central trial contact

Laurence Klotz, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems